Correlation Between Pfizer and Large Cap
Can any of the company-specific risk be diversified away by investing in both Pfizer and Large Cap at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Large Cap into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Large Cap E, you can compare the effects of market volatilities on Pfizer and Large Cap and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Large Cap. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Large Cap.
Diversification Opportunities for Pfizer and Large Cap
Average diversification
The 3 months correlation between Pfizer and Large is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Large Cap E in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Large Cap E and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Large Cap. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Large Cap E has no effect on the direction of Pfizer i.e., Pfizer and Large Cap go up and down completely randomly.
Pair Corralation between Pfizer and Large Cap
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Large Cap. In addition to that, Pfizer is 1.32 times more volatile than Large Cap E. It trades about -0.05 of its total potential returns per unit of risk. Large Cap E is currently generating about -0.02 per unit of volatility. If you would invest 2,036 in Large Cap E on December 28, 2024 and sell it today you would lose (30.00) from holding Large Cap E or give up 1.47% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Large Cap E
Performance |
Timeline |
Pfizer Inc |
Large Cap E |
Pfizer and Large Cap Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Large Cap
The main advantage of trading using opposite Pfizer and Large Cap positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Large Cap can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Large Cap will offset losses from the drop in Large Cap's long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Large Cap vs. Johcm Emerging Markets | Large Cap vs. Fidelity Series Emerging | Large Cap vs. Angel Oak Multi Strategy | Large Cap vs. Artisan Emerging Markets |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |